Skip to content

Price / book at other companies

3M logo
3MMMM
23.3×+5.5×
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
4.6×+2.9×
Biogen logo
BiogenBIIB
1.4×+0.3×
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
3.5×+0.3×
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
1.3×0.0×
Entegris logo
EntegrisENTG
4.4×+0.9×

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0.0×
Current ratio+0.1×

Where this comes from

Calculated from Rogers Corporation’s reported figures.

Based on the most recent quarter.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's price / book?
Rogers Corporation (ROG) reported price / book of 1.6× in Q1 2026.
How has Rogers Corporation's price / book changed year-over-year?
Rogers Corporation's price / book increased by 63.0% year-over-year, from 1× to 1.6×.
What is the long-term trend for Rogers Corporation's price / book?
Over 5 years (2020 to 2025), Rogers Corporation's price / book has grown at a -13.5% compound annual growth rate (CAGR), from 2.8× to 1.4×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.